Shanghai Junshi Biosciences Co., Ltd. (1877-HK) Stock Split, History Data
Working capital analysis
In terms of working capital, Shanghai Junshi Biosciences Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $5549827000.
This represents a growth rate of -22.972% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $3778142000, exhibiting a growth rate of -36.999% year-on-year.
The receivables, another significant portion of the current assets, are valued at $483226005.
The year-on-year growth rate for receivables is -6.654%.
The inventory, which forms a critical part of the assets, is valued at $538053000.
This represents a healthy year-on-year growth of -10.178%
On the liabilities side, the company's current liabilities total $2475156000.
This reflects a growth rate of 39.504% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
3778.14
5996.94
3504.61
3385.00
1214.03
2763.57
Receavebles
483.23
517.67
1834.81
663.32
164.24
0.00
Inventory
538.05
599.02
484.60
343.43
180.67
48.47
Other
744.39
91.28
7.72
306.95
352.16
92.63
Total Current Assets
5549.83
7204.90
5831.74
4698.72
1911.12
2910.18
Acc Payable
247.26
281.60
196.21
90.71
74.62
40.18
Short Term Debt
575.32
435.41
45.07
277.57
90.74
178.63
Other Current Liab
7.46
1057.24
1775.36
32.63
440.02
252.25
Current Liabilities
2475.16
1774.25
2016.63
1492.58
605.38
471.06
Capital Structure
When examining the capital structure of Shanghai Junshi Biosciences Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Shanghai Junshi Biosciences Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
